Literature DB >> 29984523

Epidemiology of rubella infection and genotyping of rubella virus in Cote d'Ivoire, 2012-2016.

Herve A Kadjo1, Diane Waku-Kouomou2, Marius Adagba1, Emily S Abernathy3, Ouattara Abdoulaye1, Edgard Adjogoua1, Fanta Coulibaly-Traore1, Sylla Aboubacar1, Ekra Daniel4, Joseph Icenogle3, Mireille Dosso1.   

Abstract

Rubella is a contagious disease caused by the rubella virus (RuV) that can lead to serious birth defects when women are infected in early pregnancy. This study aimed to describe the epidemiology and genetic diversity of rubella viruses in Cote d'Ivoire (CIV). Blood or oral fluid samples collected from suspected measles cases were first tested for the presence of measles specific IgM antibodies by enzyme-linked immunosorbent assay (ELISA). All measles IgM negative or indeterminate samples were tested for rubella IgM antibody using ELISA. Rubella-IgM-positive samples were tested by real-time reverse transcription polymerase chain reaction (RT-PCR) for the presence of rubella virus RNA. Real-time RT-PCR-positive RNA samples were used as template to amplify the 739 nt region used for rubella genotyping. PCR-positive samples were sequenced and phylogenetic analysis performed. Between 2012 and 2016, 4121 serums and 126 oral fluids were collected through the measles surveillance system. Of these, 3823 and 108 respectively were measles IgM negative or indeterminate. Subsequent testing for rubella found that 690 of 3823 (18%) serum samples and 25 of 108 (23%) oral fluid samples were rubella IgM-positive. The 739 nt segment of the E1 glycoprotein gene was amplified and sequenced for two serums and seven oral fluids samples. Phylogenetic analysis showed that the rubella viruses from CIV belonged to genotypes 1G (eight samples) and 2B (one sample). Rubella virus genotype 2B was found in CIV for the first time. These data contribute to baseline information on rubella virus strains found in CIV before the introduction of rubella vaccine.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Africa; Cote d’Ivoire; epidemiology; genotyping; rubella infection

Mesh:

Substances:

Year:  2018        PMID: 29984523      PMCID: PMC9169462          DOI: 10.1002/jmv.25252

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   20.693


  17 in total

1.  Rubella virus nomenclature update: 2013.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2013-08-09

2.  [A serological survey of rubella among pregnant women in Abidjan (author's transl)].

Authors:  M Vrinat; J Dutertre; H Helies; P Ropero
Journal:  Med Trop (Mars)       Date:  1978 Jan-Feb

3.  The epidemiological profile of rubella and congenital rubella syndrome in the United States, 1998-2004: the evidence for absence of endemic transmission.

Authors:  Susan E Reef; Susan B Redd; Emily Abernathy; Laura Zimmerman; Joseph P Icenogle
Journal:  Clin Infect Dis       Date:  2006-11-01       Impact factor: 9.079

4.  Estimating the burden of rubella virus infection and congenital rubella syndrome through a rubella immunity assessment among pregnant women in the Democratic Republic of the Congo: Potential impact on vaccination policy.

Authors:  Mary M Alleman; Kathleen A Wannemuehler; Lijuan Hao; Ludmila Perelygina; Joseph P Icenogle; Emilia Vynnycky; Franck Fwamba; Samuel Edidi; Audry Mulumba; Kassim Sidibe; Susan E Reef
Journal:  Vaccine       Date:  2016-11-17       Impact factor: 3.641

5.  [Seroprevalence of rubella in 461 pregnant women in Abidjan (Cote d'Ivoire)].

Authors:  Y H Faye-Kette; D J Sylla-Koko; G C Akoua-Koffi; A Kacou-N'Douba; L Cissel; S Bouzid; Y B Acho; B N N'Takpe; M Dosso
Journal:  Bull Soc Pathol Exot       Date:  1993

6.  Genotyping of rubella virus RNA in sera and dried blood spots collected during routine surveillance and in archival sera.

Authors:  Qi Zheng; Emily S Abernathy; Hong Sun; Zhen Zhu; Ana de Filippis; Chantal Akoua-Koffi; Hinda Ahmed; Victoria Morris-Glasgow; Margaret Quist-Therson; Joseph P Icenogle
Journal:  J Virol Methods       Date:  2012-11-29       Impact factor: 2.014

7.  [Seroepidemiology of rubella in the Ivory Coast. Geographic distribution].

Authors:  S A Ouattara; J P Brettes; R Kodjo; K Penali; G Gershy-Damet; A Sangare; Y Aron; V Akran
Journal:  Bull Soc Pathol Exot Filiales       Date:  1987

Review 8.  Fetal and neonatal abnormalities due to congenital rubella syndrome: a review of literature.

Authors:  Alexandre Yazigi; Aurelia Eldin De Pecoulas; Christelle Vauloup-Fellous; Liliane Grangeot-Keros; Jean-Marc Ayoubi; Olivier Picone
Journal:  J Matern Fetal Neonatal Med       Date:  2016-04-25

9.  Confirmation of rubella within 4 days of rash onset: comparison of rubella virus RNA detection in oral fluid with immunoglobulin M detection in serum or oral fluid.

Authors:  Emily Abernathy; Cesar Cabezas; Hong Sun; Qi Zheng; Min-hsin Chen; Carlos Castillo-Solorzano; Ana Cecilia Ortiz; Fernando Osores; Lucia Oliveira; Alvaro Whittembury; Jon K Andrus; Rita F Helfand; Joseph Icenogle
Journal:  J Clin Microbiol       Date:  2008-11-12       Impact factor: 5.948

10.  Genotypes of rubella virus and the epidemiology of rubella infections in the Democratic Republic of the Congo, 2004-2013.

Authors:  Elizabeth Pukuta; Diane Waku-Kouomou; Emily Abernathy; Benoit Kebela Illunga; Ricardo Obama; Vital Mondonge; Benjamin A Dahl; Balcha G Maresha; Joseph Icenogle; Jean-Jacques Muyembe
Journal:  J Med Virol       Date:  2016-04-05       Impact factor: 2.327

View more
  2 in total

1.  Descriptive epidemiology of rubella disease and associated virus strains in Uganda.

Authors:  Phionah Tushabe; Josephine Bwogi; Emily Abernathy; Molly Birungi; James P Eliku; Ronald Seguya; Henry Bukenya; Prossy Namuwulya; Proscovia Kakooza; Suganthi Suppiah; Theopista Kabaliisa; Mayi Tibanagwa; Immaculate Ampaire; Annet Kisakye; Andrew Bakainaga; Charles R Byabamazima; Joseph P Icenogle; Barnabas Bakamutumaho
Journal:  J Med Virol       Date:  2019-10-09       Impact factor: 2.327

2.  Rubella Eradication: Not Yet Accomplished, but Entirely Feasible.

Authors:  Stanley A Plotkin
Journal:  J Infect Dis       Date:  2021-09-30       Impact factor: 5.226

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.